Although concluding that CBG cleavage is paradoxically reduced in such patients, the study utilised an immunoassay approach to infer ‘cleaved CBG’ which has since been invalidated17, as well as the inclusion of subjects with severe AAT-deficiency who were receiving glucocorticoid therapy. The gene discussed is SERPINA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.